{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:57:09Z","timestamp":1790697429625,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"am","delay-in-days":390,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.therap.2022.01.010","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T11:04:13Z","timestamp":1643022253000},"page":"561-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in the delivery of reimbursed nicotine replacement therapies between 2016 and 2019 in France"],"prefix":"10.1016","volume":"77","author":[{"given":"Micha\u00ebl","family":"Rochoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Babol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"P\u00e9an","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Deleplanque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Berkhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2022.01.010_bib0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2013.284692","article-title":"Smoking prevalence and cigarette consumption in 187 countries, 1980\u20132012","volume":"311","author":"Ng","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.therap.2022.01.010_bib0135","series-title":"Tobacco: fact sheet","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.therap.2022.01.010_bib0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(12)61720-6","article-title":"The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK","volume":"381","author":"Pirie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2022.01.010_bib0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pneumo.2018.04.002","article-title":"Smoking in France: what is the situation?","volume":"74","author":"Josseran","year":"2018","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.therap.2022.01.010_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3917\/seve.042.0021","article-title":"The Evin law, a major step in the fight against smoking and alcoholism","volume":"1","author":"Sanfourche","year":"2014","journal-title":"Tribunes Sante"},{"key":"10.1016\/j.therap.2022.01.010_bib0155","first-page":"CD000146","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.therap.2022.01.010_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/TUI.S15628","article-title":"The economic impact of smoking and of reducing smoking prevalence: review of evidence","volume":"8","author":"Ekpu","year":"2015","journal-title":"Tob Use Insights"},{"key":"10.1016\/j.therap.2022.01.010_bib0165","series-title":"The social cost of drugs in France","author":"Kopp","year":"2015"},{"key":"10.1016\/j.therap.2022.01.010_bib0170","series-title":"Management of nicotine substitutes","author":"ameli.fr.","year":"2021"},{"key":"10.1016\/j.therap.2022.01.010_bib0175","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1111\/j.1360-0443.2009.02682.x","article-title":"Cigarettes and social differentiation in France: is tobacco use increasingly concentrated among the poor?","volume":"104","author":"Peretti-Watel","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.therap.2022.01.010_bib0180","series-title":"Open data\u00a0\u2013\u00a0drugs\u00a0\u2013\u00a0open m\u00e9dic","author":"ameli.fr.","year":"2021"},{"key":"10.1016\/j.therap.2022.01.010_bib0185","series-title":"WHO Collaborating Centre for Drug Statistics Methodology\u00a0\u2013\u00a0index de la classification ATC\/DDD","author":"Norwegian Institute of Public Health","year":"2021"},{"key":"10.1016\/j.therap.2022.01.010_bib0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ypmed.2016.07.013","article-title":"Sex\/gender differences in smoking cessation: a review","volume":"92","author":"Smith","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.therap.2022.01.010_bib0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/eurpub\/ckz171","article-title":"Changes in tobacco-related morbidity and mortality in French women: worrying trends","volume":"30","author":"Oli\u00e9","year":"2020","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.therap.2022.01.010_bib0200","series-title":"National tobacco reduction programme 2014\u20132019","author":"Minist\u00e8re des Affaires sociales de la Sant\u00e9 et des Droits des femmes","year":"2014"},{"key":"10.1016\/j.therap.2022.01.010_bib0205","series-title":"Publication of the first public health bulletins dedicated to tobacco for each region of France","author":"Sant\u00e9 publique France","year":"2017"},{"key":"10.1016\/j.therap.2022.01.010_bib0210","series-title":"Scoreboard of indicators relating to tobacco and smoking in France","author":"Observatoire fran\u00e7ais des drogues et des toxicomanies","year":"2020"},{"key":"10.1016\/j.therap.2022.01.010_bib0215","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.addbeh.2014.04.017","article-title":"Predictors of successful and unsuccessful quit attempts among smokers motivated to quit","volume":"39","author":"Smit","year":"2014","journal-title":"Addict Behav"},{"key":"10.1016\/j.therap.2022.01.010_bib0220","series-title":"Smoking and smoking cessation in 2016","author":"Lermenier-Jeannet","year":"2017"},{"key":"10.1016\/j.therap.2022.01.010_bib0225","series-title":"Smoking and smoking cessation in 2019","author":"Douchet","year":"2020"},{"key":"10.1016\/j.therap.2022.01.010_bib0230","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.addbeh.2014.08.008","article-title":"Association of amount and duration of NRT use in smokers with cigarette consumption and motivation to stop smoking: a national survey of smokers in England","volume":"40","author":"Beard","year":"2015","journal-title":"Addict Behav"},{"key":"10.1016\/j.therap.2022.01.010_bib0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0761-8425(06)71573-X","article-title":"Tobacco and adolescence: survey on motivations and knowledge of the effects of tobacco","volume":"23","author":"Hastier","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.therap.2022.01.010_bib0240","first-page":"61","article-title":"Cost effectiveness and medical cost-offset considerations in psychological service provision","volume":"44","author":"Hunsley","year":"2003","journal-title":"Can Psychol Can"},{"key":"10.1016\/j.therap.2022.01.010_bib0245","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1037\/hea0000773","article-title":"Efficacy and cost-effectiveness of behavioral interventions in nonclinical settings for improving health outcomes","volume":"38","author":"Wilson","year":"2019","journal-title":"Health Psychol"},{"key":"10.1016\/j.therap.2022.01.010_bib0250","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacl.2018.06.016","article-title":"Clinical and cost benefits of medical nutrition therapy by registered dietitian nutritionists for management of dyslipidemia: a systematic review and meta-analysis","volume":"12","author":"Sikand","year":"2018","journal-title":"J Clin Lipidol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595722000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:55:20Z","timestamp":1758567320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595722000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0040595722000129"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2022.01.010","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in the delivery of reimbursed nicotine replacement therapies between 2016 and 2019 in France","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2022.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}